Mr. Speaker, I have a petition signed by hundreds of Canadians who are concerned about the 55,000 to 75,000 Canadians who live with multiple sclerosis. The petitioners are calling upon the Government of Canada to accelerate a greater and broader participation of multiple sclerosis sufferers in pilot testing and treatment and provide fast-track funding for surveillance, research and the dissemination of findings.
The petitioners also call upon the Government of Canada to work immediately with the provinces and territories through the Canadian Agency for Drugs and Technologies to help obtain advice and evidence-based information for the effectiveness of CCSV1 without delay. They also want the federal government to take a leading role on the basis of this evidence and encourage a swift adoption of procedures in territories and provinces.